Home Healthcare Medical Devices Dry Eye Treatment Devices Market

Dry Eye Treatment Devices Market Size, Share & Trends Analysis Report By Technology (Meibomian Gland Expression (MGX), Intense Pulsed Light (IPL), Broadband Light (BBL), Combination MGX + IPL), By End-User (Hospital, Ophthalmic Clinics) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Jay Mehta | Format: | Report Code: SR2971DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Dry Eye Treatment Devices Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Meibomian Gland Expression (MGX)
    2. Intense Pulsed Light (IPL)
    3. Broadband Light (BBL)
    4. Combination MGX + IPL
  2. Dry Eye Treatment Devices Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospital
    2. Ophthalmic Clinics
  3. Regional Dry Eye Treatment Devices Market
    1. North America
      1. North America Dry Eye Treatment Devices Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
      2. North America Dry Eye Treatment Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Ophthalmic Clinics
      3. U.S.
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      4. Canada
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
    2. Europe
      1. Europe Dry Eye Treatment Devices Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
      2. Europe Dry Eye Treatment Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Ophthalmic Clinics
      3. U.K.
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      4. Germany
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      5. France
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      6. Spain
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      7. Italy
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      8. Russia
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      9. Nordic
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      10. Benelux
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      11. Rest of Europe
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
    3. APAC
      1. APAC Dry Eye Treatment Devices Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
      2. APAC Dry Eye Treatment Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Ophthalmic Clinics
      3. China
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      4. Korea
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      5. Japan
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      6. India
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      7. Australia
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      8. Taiwan
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      9. South East Asia
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      10. Rest of Asia-Pacific
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
    4. Middle East and Africa
      1. Middle East and Africa Dry Eye Treatment Devices Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
      2. Middle East and Africa Dry Eye Treatment Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Ophthalmic Clinics
      3. UAE
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      4. Turkey
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      5. Saudi Arabia
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      6. South Africa
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      7. Egypt
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      8. Nigeria
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      9. Rest of MEA
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
    5. LATAM
      1. LATAM Dry Eye Treatment Devices Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
      2. LATAM Dry Eye Treatment Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Ophthalmic Clinics
      3. Brazil
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      4. Mexico
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      5. Argentina
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      6. Chile
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      7. Colombia
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
      8. Rest of LATAM
        1. Meibomian Gland Expression (MGX)
        2. Intense Pulsed Light (IPL)
        3. Broadband Light (BBL)
        4. Combination MGX + IPL
        5. Hospital
        6. Ophthalmic Clinics
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.